Pharmacokinetics of nicotine after application of a 30 cm2 nicotine patch under steady-state conditions
- PMID: 2071260
Pharmacokinetics of nicotine after application of a 30 cm2 nicotine patch under steady-state conditions
Abstract
Transdermal nicotine systems (Nicotinell 30) were applied daily to the skin of healthy nicotine-dependent smokers for 4 days. Blood samples were taken for the measurement of nicotine and cotinine in plasma using capillary gas chromatography with nitrogen detection. The plasma concentration-time profiles of nicotine and cotinine and the pharmacokinetic parameters cmax, tmax, AUC and the elimination half-life were determined under steady-state conditions. Nicotine levels after application of the 30 cm2 patch were in accord with published values for 10, 20 and 2 x 20 cm2 patches. The elimination half-life of nicotine after removal of the patch was longer than reported values obtained after i.v. application.
Similar articles
-
Transdermal nicotine substitution: pharmacokinetics of nicotine and cotinine.Int J Clin Pharmacol Ther Toxicol. 1993 Sep;31(9):417-21. Int J Clin Pharmacol Ther Toxicol. 1993. PMID: 8225689
-
Pharmacokinetics of nicotine and cotinine after application of two different nicotine patches under steady state conditions.Arzneimittelforschung. 1992 Sep;42(9):1160-2. Arzneimittelforschung. 1992. PMID: 1445487
-
Single- and multiple-dose pharmacokinetics of Nicoderm (Nicotine Transdermal System).J Clin Pharmacol. 1993 Feb;33(2):169-74. doi: 10.1002/j.1552-4604.1993.tb03939.x. J Clin Pharmacol. 1993. PMID: 8440767 Clinical Trial.
-
Steady-state pharmacokinetics and dose relationship of nicotine delivered from Nicoderm (Nicotine Transdermal System).J Clin Pharmacol. 1993 Feb;33(2):161-8. doi: 10.1002/j.1552-4604.1993.tb03938.x. J Clin Pharmacol. 1993. PMID: 8440766 Clinical Trial.
-
Pharmacokinetics of multiple daily transdermal doses of nicotine in healthy smokers.Pharm Res. 1991 Mar;8(3):385-8. doi: 10.1023/a:1015810019076. Pharm Res. 1991. PMID: 2052530